Conferences

Catalog

Abstracts

Calendar

The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice

Accreditation: 9.75 ABIM MOC II | 9.75 AMA PRA Category 1 Credit™ | 9.75 ACPE Pharmacy

Venue: Hyatt Regency Boston, One Avenue de Lafayette, Boston, MA, 02111, United States

Start Date: November 6End Date: November 7, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

56+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binaytara

Linda Duska, MD

Conference Co-Chair

University of Virginia Comprehensive Cancer Center

Katina Robison, MD

Conference Co-Chair

Anuja Jhingran, MD

Conference Co-Chair

Keiichi Fujiwara, MD

Planning Committee

Susana Campos, MD

Planning Committee

Stephanie Lherueux, MD

Planning Committee

Dmitriy Dmitriy, MD

Planning Committee

Hematology-Oncology, Icahn School of Medicine at Mount Sinai

Ritu Salani, MD

Planning Committee

David Geffen School of Medicine at UCLA

Deb Armstrong, MD

Planning Committee

Faculty

Katina Robison, MD

Moderator

Keiichi Fujiwara, MD

Moderator

Ritu Salani, MD

Moderator

David Geffen School of Medicine at UCLA

Deb Armstrong, MD

Moderator

Carol Aghajanian, MD

Topic Presenter

Memorial Sloan Kettering Cancer Center

Ann Hoge Klopp, MD

Topic Presenter

Amanda Nickles Fader, MD

Topic Presenter

Noelle Cloven, MD

Topic Presenter

Sarah Cannon Research Institute at Texas Oncology

Alexandra Taylor, MD

Topic Presenter

Nicoletta Colombo, MD

Topic Presenter

European Institute of Oncology, IRCCS

Angeles Alvarez-Secord, MD

Topic Presenter

Duke Cancer Center

Ramez Eskander, MD

Topic Presenter

Kathleen Kathleen, MD

Topic Presenter

Joyce Liu, MD

Topic Presenter

Robert Coleman, MD

Topic Presenter

Alexander B Olawaiye, MD

Topic Presenter

University of Pittsburg School of Medicine

Bradley Corr, MD

Topic Presenter

Mike Birrer, MD

Topic Presenter

Jyoti Mayadev, MD

Topic Presenter

Jessica N. Mcalpine, MD

Topic Presenter

Kate Esselen, MD

Topic Presenter

Trey Leath, MD

Topic Presenter

Helen Mackay, MD

Topic Presenter

Debra Richardson, MD

Panelist

Debra Lynn Richardson, M.D., F.A.C.O.G., F.A.C.S

Daniela Matei, MD

Panelist

Floortje Backes, MD, MBA

Panelist

Ohio State University/The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Jonathan Andrew Ledermann, MD

Panelist

Premal Thaker, MD

Panelist

Dave Gaffney, MD PhD

Panelist

Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA

Jason Wright, MD

Panelist

Stephanie Gaillard, MD

Panelist

Johns Hopkins

Stephanie Blank, MD

Panelist

Ane Gerda Eriksen, MD

Panelist

Don Steven Dizon, MD

Panelist

Tufts Medical Center

David Huntsman

Panelist

Brad Monk

Panelist

David Mutch, MD

Panelist

Denis Querleu

Panelist

Paul A DiSilvestro, MD

Panelist

Anna Fagotti

Panelist

Alexander Melamed, MD

Panelist

Massachusetts General Hospital

Lainie Martin, MD

Panelist

Katherine Fuh

Panelist

Britt K Erickson, MD

Panelist

University of Minnesota

Gottfried Konecny

Panelist

Agenda

Day 1: Friday, November 6th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

12:00 PM - 01:00 PMRegistration, Lunch & Exhibits

01:00 PM - 01:20 PMWelcome & Meeting Introduction (Non-CME Accredited)

01:20 PM - 02:25 PMSession 1a : Applying Precision Therapy in the Adjuvant Setting (Part One)

Session Chair: Anuja Jhingran, MD

01:20 PM - 01:30 PM

Molecular staging of endometrial cancer: approach to p53 abnormal tumors – Carol Aghajanian, MD

01:30 PM - 01:40 PM

A critical review of the role of radiation in early-stage endometrial cancer – Ann Hoge Klopp, MD

01:40 PM - 02:10 PM

Discussion

Moderators:

Anuja Jhingran, MD

Panelists:

Carol Aghajanian, MD; Ann Hoge Klopp, MD; Daniela Matei, MD; Floortje Backes, MD, MBA

02:10 PM - 02:25 PM

Vote (audience participation, panel vote)

02:25 PM - 02:40 PMBreak & Exhibits

02:40 PM - 03:45 PMSession 1b : Applying Precision Therapy in the Adjuvant Setting (Part One).

Session Chair: Stephanie Lherueux, MD

02:40 PM - 02:50 PM

Adjuvant PARP inhibitors: Update on long-term benefit – Robert Coleman, MD

02:50 PM - 03:00 PM

Is there a role for PARPi after progression on a prior PARPi? – Joyce Liu, MD

03:00 PM - 03:30 PM

Discussion

Moderators:

Stephanie Lherueux, MD

Panelists:

Robert Coleman, MD; Joyce Liu, MD; Jason Wright, MD; Jonathan Andrew Ledermann, MD

03:30 PM - 03:45 PM

Vote (audience participation, panel vote)

03:45 PM - 04:00 PMBreak & Exhibits

04:00 PM - 05:15 PMSession 2a : Novel Agents in Platinum-Resistant Ovarian Cancer.

Session Chair: Linda Duska, MD

04:00 PM - 04:10 PM

The current state of FOLR1 directed treatments: mirvetuximab and beyond – Kathleen Kathleen, MD

04:10 PM - 04:20 PM

B96 Trial – Nicoletta Colombo, MD

04:20 PM - 04:30 PM

Rosella – Alexander B Olawaiye, MD

04:30 PM - 05:00 PM

Discussion

Moderators:

Linda Duska, MD

Panelists:

Kathleen Kathleen, MD; Nicoletta Colombo, MD; Alexander B Olawaiye, MD; Debra Richardson, MD; Premal Thaker, MD

05:00 PM - 05:15 PM

Vote (audience participation, panel vote)

Day 2: Saturday, November 7th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, and Exhibits

08:00 AM - 08:05 AMWelcome (non-CME accredited)

08:05 AM - 09:10 AMSession 2b : ADCs in Gynecologic Cancer.

Session Chair: Dmitriy Dmitriy, MD

08:05 AM - 08:15 AM

The role of ADCs in endometrial cancer – Noelle Cloven, MD

08:15 AM - 08:25 AM

Targeting HER2: is earlier better? – Amanda Nickles Fader, MD

08:25 AM - 08:55 AM

Discussion

Moderators:

Dmitriy Dmitriy, MD

Panelists:

Noelle Cloven, MD; Amanda Nickles Fader, MD; Stephanie Gaillard, MD

08:55 AM - 09:10 AM

Vote (audience participation, panel vote)

09:10 AM - 09:20 AMBreak & Exhibits

09:20 AM - 11:20 AMSession 3 : Applying Precision Therapy in the Adjuvant Setting (Part Two)

Session Chair: Katina Robison, MD

09:20 AM - 09:30 AM

The role of checkpoint inhibitors in dMMR endometrial cancer – Ramez Eskander, MD

09:30 AM - 09:40 AM

Options and endpoints with adjuvant RT for endometrial cancer – Alexandra Taylor, MD

09:40 AM - 10:00 AM

Discussion

Moderators:

Katina Robison, MD

Panelists:

Don Steven Dizon, MD; Ramez Eskander, MD; Alexandra Taylor, MD

10:00 AM - 10:15 AM

POLE-endometrial cancer: Does stage matter? – Jessica N. Mcalpine, MD

10:15 AM - 10:35 AM

Discussion

Moderators:

Katina Robison, MD

Panelists:

David Mutch, MD; Jessica N. Mcalpine, MD; David Huntsman

10:35 AM - 10:45 AM

A critical evaluation of checkpoint inhibitors in cervical cancer: PD-L1 and beyond – Trey Leath, MD

10:45 AM - 11:05 AM

Discussion

Moderators:

Katina Robison, MD

Panelists:

Trey Leath, MD; Denis Querleu ; Paul A DiSilvestro, MD

11:05 AM - 11:20 AM

Vote (audience participation, panel vote)

About The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship